Piper Sandler raised the firm’s price target on Comerica to $54 from $53 and keeps a Neutral rating on the shares. Comerica’s core Q1 results came in better than the firm had anticipated, primarily thanks to lesser net interest income degradation than the firm had modeled, the analyst tells investors in a research note. The story’s main leverage will likely come post-Q2, when NII should begin a substantial upward trajectory thanks to a combination of anticipated loan growth rebound and swap/securities portfolio maturities becoming a more visible tailwind, Piper says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
